HSPA5 and neoplasm: All the treatments—RGD4C/AAVP‐Grp78‐HSVtk/GCV, TMZ alone, and combination of RGD4C/AAVP‐Grp78‐HSVtk/GCV plus TMZ—increased the survival of tumor‐bearing mice (Fig 4D).